Gland Pharma

Rediff.com » News » Gland Pharma

News for Gland Pharma

News
Business

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

As more and more states flag shortage of COVID-19 vaccine doses, the Central government has pressed the accelerator to scale up vaccine production manifold. Top government sources said that by end......

Russia reaches out to Kerala for Sputnik V plant

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms......

India to produce 850mn Sputnik doses annually: RDIF

The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has also given approval for the emergency......

'Sputnik V provides immunity for a longer duration'

'Its efficacy is 97.6 per cent.' Morepen India Chairman and Managing Director Sushil Suri in an interview with Uddalok Bhattacharya says the Sputnik V vaccine it is manufacturing in India......

Sputnik V vaccine may be added to India's Covid armoury soon

‘We expect to get the approval in the next few weeks,’ says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL). IMAGE: Medics administer the first......

Why investors are regretting giving Gland Pharma IPO a miss

Gland Pharma, promoted by China's Fosun, has extended its gains, is up 40 per cent since its listing. Illustration: Uttam Ghosh/Rediff.com Retail and high-networth individuals (HNIs) would be......

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. Gland Pharma's......

Shanghai Fosun to buy Gland Pharma for $1.4 billion

Rare deal of a Chinese drug firm buying an Indian company likely this week Hong Kong-listed Shanghai Fosun Pharmaceutical (Group) has agreed to buy Hyderabad-based Gland Pharma, backed by private......

Can MFN Pricing Reshape India-US Pharma Equation?

US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent). Illustration: Uttam......

Key mantra for India's pharma sector in 2023

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......

Gland Pharma

News for Gland Pharma

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

Russia reaches out to Kerala for Sputnik V plant

India to produce 850mn Sputnik doses annually: RDIF

'Sputnik V provides immunity for a longer duration'

Sputnik V vaccine may be added to India's Covid armoury soon

Why investors are regretting giving Gland Pharma IPO a miss

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Shanghai Fosun to buy Gland Pharma for $1.4 billion

Can MFN Pricing Reshape India-US Pharma Equation?

Key mantra for India's pharma sector in 2023

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS